We have advised a medical device manufacturer on the regulatory implications of the restriction on synthetic polymer microparticles for its products.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type
Sectors (2)
Expertises
34 results
Newest first
We advised a mid-sized company on the qualification of a cosmetic product to facilitate its compliant and effective market launch.
Our team negotiated a cooperation agreement between a cosmetics brand owner and a manufacturer on behalf of a mid-sized company.
Axon assisted the shareholders of a Dutch medtech company, specialising in epilepsy detection devices, in the sale of the company to a Scandinavian healthcare technology group. We advised on the transaction structure, share purchase documentation and related matters.